For example, in the production of active ingredients, Europe’s market share by value has slumped. While it exceeded 80% at the end of the 1990s, it had fallen to 48% by 2014. “Today, it’s closer to 30%, and it’s likely to drop further,” noted Vincent Touraille, president of SICOS, France’s union of players in the organic chemistry and biochemistry industries. Meanwhile, China and India have soared to reach respective market shares of 35% and 20%.
A study conducted by German generic drug industry association Pro Generika found that at least three commonly used antibiotics – doxycycline, clarithromycin and cefaclor – now have only one or two manufacturers left in Europe. More broadly, 80% of the active ingredients in medicines consumed on the continent now come from India or China.
I don’t really understand how the title relates to the article, which mostly points out that European drug manufacturers can’t sell so much stuff in the USA anymore, which is apparently a huge market.
So what? Markets shift, markets change, yadda yadda.
I wish news outlets would use equally dramatic titles when people’s pay can’t keep up with cost of living.
PS: I keep confusing Le Monde and Le Monde Diplomatique. Damn.